The pharma and biotech industries are navigating tighter capital, evolving regulations, and rising competition from breakthrough therapies in oncology, rare diseases, and obesity. Against this backdrop, the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, will bring together leading biopharma companies, emerging innovators, investors, and healthcare technology developers. The event will highlight corporate updates on commercial performance, clinical progress, regulatory milestones, and strategic priorities.
Below are key updates from a few companies scheduled to present at the conference.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com